TRAE/GBIC: GBIC in Final Negotiations to Expand into High Growth Oil and Gas Industry
Monday May 8, 7:49 am ET
Shareholders to Receive Earnings from Herbal and Energy Operations
HOUSTON--(BUSINESS WIRE)--May 8, 2006--Gulf Biomedical Corporation (OTC PK: GBIC) is pleased to announce they are in final negotiations with Triton American Energy (OTC PK: TRAE), for the purchase of oil and gas wells in the Corsicana, Texas area. Acquisitions are designed to position Gulf Biomedical to generate accelerated earnings in two high growth industries. Income from oil and gas well operations will directly flow into Gulf Biomedicals earnings.
ADVERTISEMENT
Under the terms of agreement, Gulf Biomedical will utilize Triton American Energy to drill and recover oil and gas from existing wells. Revenue from these wells is anticipated to generate long-term residual revenues.
During the last thirty years oil and gas has consistently soared to record highs. Within the last week, crude oil reached a new high of $75.00 per barrel. Based on global and political pressures, analysts are forecasting crude oil to reach $95.00 per barrel in less than twelve months.
Don West, President of Gulf Biomedical stated "In 2006 we have had numerous high revenue generating business opportunities presented to our company. After much consideration, we have determined diversifying our revenue stream into a second high growth industry will fuel accelerated earnings and corporate expansion. Income from our well operations will directly flow into Gulf Biomedicals earnings". Mr. West continued to state "Our well acquisitions will in no way affect our growing order demand of herbal products. We will continue to build out our product lines, pursue infomercials and increase our dedicated customer base."
About Gulf Biomedical:
Gulf Biomedical (OTC PK: GBIC) is focused on providing herbal products which are safe, reliable and backed by quality customer service. Currently, Gulf Biomedical is targeting four high revenue generating segments, Erectile Dysfunction, Hair Restoration, Anti-Depression and Weight Loss. Over 91 million people within the United States take herbal supplements to improve their health. This number is large due to the significant and even fatal side-effects of well known drugs which were once approved by the Food and Drug Administration.
For more information on becoming a distributor, please contact Investor Relations at (973) 351-3868 or Customer Service at 973-375-5002.
To subscribe to receive updates on Gulf Biomedicals latest product developments or stock updates please visit the website at www.Herbalstore.us.
Disclaimer: This news release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of l995 relating to aspects of the Company's operations and strategies. Important factors could occur to cause actual results to differ materially from those described herein. There is a risk that the Company may incur losses. Readers are urged to consider these cautionary statements carefully. Forward-looking statements speak only as of the date of this news release, and the Company disclaims any obligations to update such statements.
Contact:
Gulf Biomedical Corporation
Investor Relations:
Stephen Taylor, 973-351-3868
STEPHTAYL9@AOL.COM
www.Herbalstore.us
or
Customer Service:
973-375-5002
